Clinical Trials Logo

Manic Episode clinical trials

View clinical trials related to Manic Episode.

Filter by:
  • None
  • Page 1

NCT ID: NCT05956340 Recruiting - Bipolar I Disorder Clinical Trials

A Study of Spoken Language in Mania

Start date: April 19, 2023
Phase: N/A
Study type: Interventional

This research is being done to find if there are changes with voice and speech during episodes of mania.

NCT ID: NCT05622552 Recruiting - Manic Episode Clinical Trials

Effect of tDCS Combined With Pharmacological Treatments for Bipolar Mania

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to conduct a randomized double-blind controlled trial to explore the efficacy and safety of transcranial direct current stimulation (tDCS) in the treatment of manic episode (ME) and analyzes the brain functional connectivity to construct the therapeutic effect prediction model of tDCS for ME. The main questions it aims to answer are: - A randomized double-blind controlled trial is conducted to clarify the efficacy and safety of tDCS combined with pharmacological treatments in the ME. - A therapeutic effect prediction model of tDCS for ME by using functional near-infrared spectroscopy to evaluate brain function. Participants will be receive: - clinical data interview and clinical symptom assessment. - the functional near-infrared spectroscopy (fNIRS) to analysis brain functional connectivity. - tDCS stimulation, which was performed once a day sessions of active or sham anodal tDCS to the right dorsolateral prefrontal cortex and Cathode to the left OFC (2 mA, 20 minutes, 10 sessions). In the active group, current stimulations were gradually ramped up to 2 mA (in 30 seconds) intensity for 20 minutes, once a day, for 10 days. For sham stimulation, the procedure was identical, except that the current was gradually ramped up to 2mA and rapidly down to zero (in 30 seconds), thus leading to the same initial sensations of tDCS.

NCT ID: NCT03259555 Completed - Bipolar I Disorder Clinical Trials

A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder

Start date: September 14, 2017
Phase: Phase 3
Study type: Interventional

To demonstrate the efficacy of brexpiprazole for the acute treatment of manic episodes, with or without mixed features, in participants with a diagnosis of bipolar I disorder.

NCT ID: NCT03257865 Completed - Bipolar I Disorder Clinical Trials

A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder

Start date: September 19, 2017
Phase: Phase 3
Study type: Interventional

To demonstrate the efficacy of brexpiprazole for the acute treatment of manic episodes, with or without mixed features, in participants with a diagnosis of bipolar I disorder.

NCT ID: NCT00257075 Completed - Bipolar Disorders Clinical Trials

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder

Start date: December 2000
Phase: Phase 3
Study type: Interventional

The purpose of the study is to assess the effectiveness and safety of risperidone (an antipsychotic medication) versus placebo during 3 weeks of treatment of mania in patients with Bipolar I Disorder who are suffering a manic episode.

NCT ID: NCT00249236 Completed - Bipolar Disorder Clinical Trials

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

Start date: March 2001
Phase: Phase 3
Study type: Interventional

The purpose of the study is to assess the effectiveness and safety of risperidone (an antipsychotic medication) versus placebo in treating mania during 3 weeks of treatment in patients with Bipolar I Disorder who suffer from manic or mixed episodes.